(HLNE) Hamilton Lane - Ratings and Ratios
Private Equity, Venture Capital, Alternative Investments, Asset Management
HLNE EPS (Earnings per Share)
HLNE Revenue
Description: HLNE Hamilton Lane
Hamilton Lane Incorporated is a global private equity and venture capital firm that manages alternative investment strategies across various asset classes, including private equity, credit, and real assets. The firm has a diverse investment focus, targeting companies with disruptive technologies and innovative business models across multiple industries, such as technology, healthcare, and energy.
From a business perspective, Hamilton Lanes key strength lies in its ability to provide a range of investment solutions to its clients, including primary and secondary fund investments, direct credit, and real assets. The firms global presence, with offices across Europe, North America, Asia Pacific, and the Middle East, allows it to tap into a broad range of investment opportunities and provide access to international markets.
Some key performance indicators (KPIs) that can be used to evaluate Hamilton Lanes performance include Assets Under Management (AUM) growth, investment performance (e.g., IRR, multiple on invested capital), and client acquisition and retention rates. With an ROE of 34.25%, the firm demonstrates a strong ability to generate returns on equity. Additionally, the firms P/E ratio of 28.07 and forward P/E of 37.04 suggest that the market expects continued growth in earnings.
From an investment perspective, Hamilton Lanes focus on innovative companies and disruptive technologies could potentially lead to significant returns, but also involves higher risk. The firms willingness to take majority stakes in companies and invest between $0.25 million and $100 million in small- to mid-sized enterprises suggests a flexible investment approach. Investors should consider the firms historical investment performance, as well as the overall market environment, when evaluating the potential for future growth.
HLNE Stock Overview
| Market Cap in USD | 8,341m |
| Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 2017-03-01 |
HLNE Stock Ratings
| Growth Rating | 34.8% |
| Fundamental | 86.2% |
| Dividend Rating | 66.4% |
| Return 12m vs S&P 500 | -20.8% |
| Analyst Rating | 2.83 of 5 |
HLNE Dividends
| Dividend Yield 12m | 1.37% |
| Yield on Cost 5y | 3.67% |
| Annual Growth 5y | 9.54% |
| Payout Consistency | 100.0% |
| Payout Ratio | 42.6% |
HLNE Growth Ratios
| Growth Correlation 3m | 29.1% |
| Growth Correlation 12m | -51.6% |
| Growth Correlation 5y | 71.9% |
| CAGR 5y | 31.01% |
| CAGR/Max DD 3y | 0.84 |
| CAGR/Mean DD 3y | 4.96 |
| Sharpe Ratio 12m | 0.12 |
| Alpha | 0.11 |
| Beta | 0.747 |
| Volatility | 33.51% |
| Current Volume | 236.3k |
| Average Volume 20d | 314.9k |
| Stop Loss | 141.2 (-3.4%) |
| Signal | -1.26 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (212.2m TTM) > 0 and > 6% of Revenue (6% = 41.5m TTM) |
| FCFTA 0.19 (>2.0%) and ΔFCFTA 9.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 27.81% (prev 14.03%; Δ 13.78pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 356.2m > Net Income 212.2m (YES >=105%, WARN >=100%) |
| Net Debt (49.6m) to EBITDA (315.6m) ratio: 0.16 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.60 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (54.5m) change vs 12m ago 0.78% (target <= -2.0% for YES) |
| Gross Margin 61.43% (prev 68.25%; Δ -6.82pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 43.62% (prev 45.60%; Δ -1.98pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 21.50 (EBITDA TTM 315.6m / Interest Expense TTM 14.2m) >= 6 (WARN >= 3) |
Altman Z'' 3.51
| (A) 0.11 = (Total Current Assets 510.9m - Total Current Liabilities 318.4m) / Total Assets 1.80b |
| (B) 0.27 = Retained Earnings (Balance) 486.9m / Total Assets 1.80b |
| (C) 0.19 = EBIT TTM 306.1m / Avg Total Assets 1.59b |
| (D) 0.60 = Book Value of Equity 487.1m / Total Liabilities 807.0m |
| Total Rating: 3.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.20
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 3.99% = 1.99 |
| 3. FCF Margin 49.73% = 7.50 |
| 4. Debt/Equity 0.80 = 2.19 |
| 5. Debt/Ebitda 1.92 = 0.15 |
| 6. ROIC - WACC (= 19.71)% = 12.50 |
| 7. RoE 31.07% = 2.50 |
| 8. Rev. Trend 70.23% = 5.27 |
| 9. EPS Trend 61.99% = 3.10 |
What is the price of HLNE shares?
Over the past week, the price has changed by -2.09%, over one month by -5.97%, over three months by +7.95% and over the past year by -6.17%.
Is Hamilton Lane a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HLNE is around 155.92 USD . This means that HLNE is currently overvalued and has a potential downside of 6.7%.
Is HLNE a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the HLNE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 160.3 | 9.7% |
| Analysts Target Price | 160.3 | 9.7% |
| ValueRay Target Price | 173.4 | 18.7% |
Last update: 2025-09-16 04:35
HLNE Fundamental Data Overview
CCE Cash And Equivalents = 315.9m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 28.5038
P/E Forward = 33.3333
P/S = 12.0499
P/B = 8.6041
P/EG = 1.39
Beta = 1.276
Revenue TTM = 692.2m USD
EBIT TTM = 306.1m USD
EBITDA TTM = 315.6m USD
Long Term Debt = 288.6m USD (from longTermDebt, last quarter)
Short Term Debt = 318.4m USD (from totalCurrentLiabilities, last quarter)
Debt = 607.0m USD (Calculated: Short Term 318.4m + Long Term 288.6m)
Net Debt = 49.6m USD (from netDebt column, last quarter)
Enterprise Value = 8.63b USD (8.34b + Debt 607.0m - CCE 315.9m)
Interest Coverage Ratio = 21.50 (Ebit TTM 306.1m / Interest Expense TTM 14.2m)
FCF Yield = 3.99% (FCF TTM 344.2m / Enterprise Value 8.63b)
FCF Margin = 49.73% (FCF TTM 344.2m / Revenue TTM 692.2m)
Net Margin = 30.66% (Net Income TTM 212.2m / Revenue TTM 692.2m)
Gross Margin = 61.43% ((Revenue TTM 692.2m - Cost of Revenue TTM 267.0m) / Revenue TTM)
Tobins Q-Ratio = 17.72 (Enterprise Value 8.63b / Book Value Of Equity 487.1m)
Interest Expense / Debt = 0.64% (Interest Expense 3.86m / Debt 607.0m)
Taxrate = 13.39% (48.5m / 362.3m)
NOPAT = 265.1m (EBIT 306.1m * (1 - 13.39%))
Current Ratio = 1.60 (Total Current Assets 510.9m / Total Current Liabilities 318.4m)
Debt / Equity = 0.80 (Debt 607.0m / last Quarter total Stockholder Equity 758.8m)
Debt / EBITDA = 1.92 (Net Debt 49.6m / EBITDA 315.6m)
Debt / FCF = 1.76 (Debt 607.0m / FCF TTM 344.2m)
Total Stockholder Equity = 683.0m (last 4 quarters mean)
RoA = 11.78% (Net Income 212.2m, Total Assets 1.80b )
RoE = 31.07% (Net Income TTM 212.2m / Total Stockholder Equity 683.0m)
RoCE = 31.51% (Ebit 306.1m / (Equity 683.0m + L.T.Debt 288.6m))
RoIC = 27.93% (NOPAT 265.1m / Invested Capital 949.4m)
WACC = 8.21% (E(8.34b)/V(8.95b) * Re(8.77%)) + (D(607.0m)/V(8.95b) * Rd(0.64%) * (1-Tc(0.13)))
Shares Correlation 3-Years: 60.61 | Cagr: 0.12%
Discount Rate = 8.77% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 78.68% ; FCFE base≈259.9m ; Y1≈311.4m ; Y5≈496.4m
Fair Price DCF = 168.6 (DCF Value 7.40b / Shares Outstanding 43.9m; 5y FCF grow 21.12% → 3.0% )
EPS Correlation: 61.99 | EPS CAGR: 9.53% | SUE: 1.63 | # QB: 1
Revenue Correlation: 70.23 | Revenue CAGR: 5.12% | SUE: 0.86 | # QB: 1
Additional Sources for HLNE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle